title: Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease.
abstract: Distinct luteinizing hormone receptor (LHR) protein variants exist due to the posttranslational modifications. Besides ovaries, LHR immunoreactivity (LHRI) was also found in other tissues, such as the brain, fallopian tube, endometrium, trophoblast and resident tissue macrophages. The 3B5 mouse monoclonal antibody was raised against purified rat LHR. In rat, porcine and human ovaries, the 3B5 identified six distinct LHR bands migrating at approximately 92, 80, 68, 59, 52 and 48 kDa. Characteristic LHRI was detected in rat, human and porcine corpora lutea. During cellular differentiation, subcellular LHR distribution changed from none to granular cytoplasmic, perinuclear, surface, nuclear and no staining. There were also differences in vascular LHR expression--lack of LHRI in ovarian vessels and strong staining of vessels in other tissues investigated. In normal human term placentae, villous LHRI was associated with blood sinusoids and cytotrophoblast cells, and rarely detected in trophoblastic syncytium. In all abnormal placentae, the LHRI of sinusoids was absent, and syncytium showed either enhanced (immature placental phenotypes) or no LHRI (aged placental phenotype). LHRI in human brain was identified in microglial cells (CD68+ resident macrophages). Protein extracts from human vaginal wall and levator ani muscle and fascia showed strong approximately 92 and 68 kDa species, and LHRI was detected in smooth muscle cells, fibroblasts, resident macrophages and nuclei of skeletal muscle fibers. Our observations indicate that, in contrast to the theory on the role of vascular hormone receptors in preferential pick up of circulating hormones, there is no need to enhance selective pick up rather only prevent LH/CG transport to inappropriate sites. Abnormal placental LHR expression may play a role in the development of abnormal pregnancy. Expression of LHR in the pelvic floor compartments suggests that high LH levels in postmenopausal women may contribute to the pelvic floor relaxation and increased incidence of pelvic floor disorders. Since chorionic gonadotropin increases secretion of a variety of cytokines by monocytes, and induces their inflammatory reaction and phagocytic activity, high LH levels in aging individuals may also activate microglia (mononuclear phagocyte system in the central nervous system) and contribute to the development of Alzheimer's disease and other inflammation-mediated neurodegenerative diseases.
authors.affiliation: Laboratory for Development, Differentiation and Cancer, Department of Obstetrics and Gynecology, The University of Tennessee Graduate School of Medicine, 1924 Alcoa Highway, Knoxville, TN 37920, USA. buko@utk.edu
authors.forename: Antonin
authors.initials: A
authors.lastname: Bukovsky
authors.forename: Korakod
authors.initials: K
authors.lastname: Indrapichate
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fujiwara
authors.forename: Maria
authors.initials: M
authors.lastname: Cekanova
authors.forename: Maria E
authors.initials: ME
authors.lastname: Ayala
authors.forename: Roberto
authors.initials: R
authors.lastname: Dominguez
authors.forename: Michael R
authors.initials: MR
authors.lastname: Caudle
authors.forename: Jay
authors.initials: J
authors.lastname: Wimalsena
authors.forename: Robert F
authors.initials: RF
authors.lastname: Elder
authors.forename: Pleas
authors.initials: P
authors.lastname: Copas
authors.forename: James S
authors.initials: JS
authors.lastname: Foster
authors.forename: Romaine I
authors.initials: RI
authors.lastname: Fernando
authors.forename: Donald C
authors.initials: DC
authors.lastname: Henley
authors.forename: Nirmala B
authors.initials: NB
authors.lastname: Upadhyaya
mesh_terms: D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism; D000818:Animals; D001808:Blood Vessels / Q000737:chemistry; D001923:Brain Chemistry; D006063:Chorionic Gonadotropin / Q000502:physiology; D003338:Corpus Luteum / Q000737:chemistry; D005260:Female; D005836:Genitalia, Female / Q000098:blood supply / Q000737:chemistry; D006801:Humans; D007124:Immunoenzyme Techniques; D007986:Luteinizing Hormone / Q000502:physiology; D017628:Microglia / Q000737:chemistry; D008970:Molecular Weight; D009124:Muscle Proteins / Q000032:analysis / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000737:chemistry / Q000502:physiology; D009928:Organ Specificity; D010053:Ovary / Q000098:blood supply / Q000737:chemistry; D017773:Pelvic Floor; D010920:Placenta / Q000098:blood supply / Q000737:chemistry*; D010922:Placenta Diseases / Q000209:etiology / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology / Q000378:metabolism; D020033:Protein Isoforms / Q000737:chemistry / Q000502:physiology; D011499:Protein Processing, Post-Translational; D051381:Rats / Q000502:physiology*; D011974:Receptors, LH / Q000032:analysis / Q000737:chemistry / Q000502:physiology*; D013347:Subcellular Fractions / Q000737:chemistry; D013552:Swine / Q000502:physiology*
chemical_list: D006063:Chorionic Gonadotropin; D009124:Muscle Proteins; D009419:Nerve Tissue Proteins; D020033:Protein Isoforms; D011974:Receptors, LH; D007986:Luteinizing Hormone